HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies

Current Opinion in Organ Transplantation

Volumn 14, Issue 4, 2009, Pages 403-409

  Duquesnoy, René J ^a   Marrari, Marilyn ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Antigenicity; HLAMatchmaker; Human leukocyte antigen antibody; Human leukocyte antigen epitope; Immunogenicity

Indexed keywords

ALLOANTIBODY; EPITOPE; HLA ANTIGEN;

ALGORITHM; DNA POLYMORPHISM; HLA MATCHING; HUMAN; IMMUNE RESPONSE; NEPHRECTOMY; REVIEW;

ALGORITHMS; ANTIBODY SPECIFICITY; COMPUTER SIMULATION; EPITOPE MAPPING; EPITOPES; GRAFT REJECTION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ISOANTIBODIES; MODELS, MOLECULAR; ORGAN TRANSPLANTATION; PROTEIN CONFORMATION; TISSUE DONORS;

EID: 68849101124     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32832ca2b8     Document Type: Review

References (35)

1. Duquesnoy RJ. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006; 67:847-862.
2. Duquesnoy RJ, Askar M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination V. Eplet Matching for HLA-DR, HLA-DQ and HLA-DP. Hum Immunol 2007; 68:12-25.
3. Duquesnoy RJ. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Hum Immunol 2002; 63:339-352.
4. Duquesnoy R. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation. Curr Opin Immunol 2008; 20:594-601. This study shows illustrations of HLA polymorphisms, how mismatched epitope loads depend on the HLA phenotypes of recipients and affect antibody responses and transplant outcome and the principles of epitope matching.
5. Duquesnoy RJ, Takemoto S, De Lange P, et al. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival. Transplantation 2003; 75:884-889.
6. Boehringer D, Reinhard T, Duquesnoy R, et al. Beneficial effect of matching at the HLA-A and B amino-acid triplet level on rejection free survival in penetrating keratoplasty. Transplantation 2004; 77:417-421. (Pubitemid 38209742)
7. Claas FHJ, Witvliet M, Duquesnoy RJ, et al. The acceptable mismatch program as a fast tool to transplant highly sensitized patients awaiting a post-mortal kidney: short waiting time and excellent graft outcome. Transplantation 2004; 78:190-193. (Pubitemid 39525336)
8. Duquesnoy RJ, Witvliet MJ, Doxiadis IIN, et al. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates. Transpl Int 2004; 7:31-38.
9. Doxiadis IIN, Duquesnoy RJ, Claas FHJ. Extending options for highly sensitized patients to receive a suitable kidney graft. Curr Opin Immunol 2005; 17:536-540.
10. Haririan A, Fagoaga O, Daneshvar H, et al. Predictive value of HLA epitope matching using HLAMatchmaker for graft outcomes in a predominantly African-American renal transplant cohort. Clin Transplant 2006; 20:226-233.
11. Valentini RP, Nehlsen-Cannarella SL, Gruber SA, et al. Intravenous immunoglubulin, HLA allele typing and HLAMatchmaker facilitate successful transplantation in highly sensitized pediatric renal allograft recipients. Pediatr Transplant 2007; 11:77-81.
12. Duquesnoy RJ. 'Match and Treat', an effective strategy for transplanting highly sensitized pediatric transplant candidates? (Invited Editorial). Pediatr Transplant 2007; 11:3-4.
13. Kosmoliaptsis V, Bradley J, Sharples L, et al. Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker. Transplantation 2008; 85:1817-1825.
14. Duquesnoy R. HLA class II antibodies and transplant outcome (invited editorial). Transplantation 2008; 86:638-640.
15. Nambiar A, Duquesnoy RJ, Adams S, et al. HLAMatchmaker-driven analysis of response to HLA matched platelet transfusions in alloimmunized patients. Blood 2006; 107:1680-1687. (Pubitemid 43242409)
16. Duquesnoy R. Structural epitope matching for HLA alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support? Transfusion 2008; I48:221-227.
17. Brooks E, MacPherson B, Fung M. Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions. Transfusion 2008; 48:2159-2166.
18. Claas FHJ, Dankers MK, Oudshoorn M, et al. Differential immunogenicity of HLA mismatches in clinical transplantation. Transplant Immunol 2005; 14:187-191. (Pubitemid 40848525)
19. Goodman R, Taylor C, O'Rourke C, et al. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitised patients awaiting kidney transplantation. Transplantation 2006; 81:1331-1336. (Pubitemid 43804555)
20. Duquesnoy R, Mostecki J, Hariharan J, Balasz I. A structurally based epitope analysis of MICA antibody specificity patterns. Hum Immunol 2008; 69:826-832.
21. Dankers MKA, Witvliet MD, Roelen DL, et al. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched HLA antigens. Transplantation 2004; 128:1236-1239.
22. Mihaylova A, Baltadjieva D, Boneva P, et al. Clinical relevance of anti-HLA antibodies detected by flow-cytometry bead-based assays: single-center experience. Hum Immunol 2006; 67:787-794. (Pubitemid 44572595)
23. Duquesnoy R, Awadalla Y, Lomago J, et al. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR, DQ, DP epitopes. Transpl Immunol 2008; 18:352-360. (Pubitemid 350302034)
24. Duquesnoy RJ, Claas FHJ. Progress report of 14th International Histocompatibility Workshop Project on the structural basis of HLA compatibility. Tissue Antigens 2007; 69 (Suppl 1):180-184. (Pubitemid 46625880)
25. Adeyi OE, Girnita A, Awadalla Y, et al. Serum analysis after kidney transplant nephrectomy reveals restricted antibody specificity patterns against donor HLA class I antigens. Transpl Immunol 2005; 14:53-62.
26. Marrari M, Duquesnoy R. Why can sensitization by a HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1? Hum Immunol 70 (6) June 2009. [Epub ahead of print]
27. Cai J, Terasaki P. Posttransplantation antibody monitoring and HLA antibody epitope identification. Curr Opin Immunol 2008; 20:602-606.
28. El-Awar NR, Akaza T, Terasaki PI, et al. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus. Transplantation 2007; 84:532-540. (Pubitemid 47312166)
29. Cai J, Terasaki PI, Mao Q, et al. Development of nondonor-specific HLA-DR antibodies in allograft recipients is associated with shared epitopes with mismatched donor DR antigens. Am J Transplant 2006; 6:2947-2954. (Pubitemid 44777925)
30. Deng CT, El-Awar N, Ozawa M, et al. Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients. Transplantation 2008; 86:452-459.
31. Duquesnoy R, Marrari M. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens. Tissue Antigens 2009 (in press). This study describes the relationship between eplets and class I epitopes specifically recognized by antibodies.
32. Marrari M, Duquesnoy R. Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR, -DQ and -DP antigens. Tissue Antigens (in press). This study describes the relationship between eplets and class II epitopes defined by specific antibodies.
33. Duquesnoy RJ, Mulder A, Askar M, et al. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes. Hum Immunol 2005; 66:749-761. (Pubitemid 41174564)
34. Lutz CT, Smith KD, Greazel NS, et al. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix. J Immunol 1994; 153:4099-4110.
35. Akkoc N, Scornik JC. HLA epitope matching. Contribution of matched residues to epitopes recognized by alloantibodies. Transplantation 1991; 52:903-907.